Drug eluting coronary stents.
作者信息
Jenkins N P, Prendergast B D, Thomas M
出版信息
BMJ. 2002 Dec 7;325(7376):1315-6. doi: 10.1136/bmj.325.7376.1315.
Abstract
摘要
相似文献
1
Drug eluting coronary stents.药物洗脱冠状动脉支架
BMJ. 2002 Dec 7;325(7376):1315-6. doi: 10.1136/bmj.325.7376.1315.
2
Drug-eluting stents: the panacea for restenosis?药物洗脱支架：治疗再狭窄的万灵药？
Singapore Med J. 2004 Jul;45(7):300-2.
3
Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.药物洗脱支架在糖尿病患者与非糖尿病患者中的疗效：对照试验的间接比较
Heart. 2006 May;92(5):650-7. doi: 10.1136/hrt.2005.070698. Epub 2005 Oct 26.
4
[Sirolimus-eluting vs paclitaxel-eluting stents -- the trials confirm differences in clinical outcome].西罗莫司洗脱支架与紫杉醇洗脱支架——试验证实临床结果存在差异
Kardiol Pol. 2005 Nov;63(5):574-6; discussion 577.
5
A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease.一项关于紫杉醇洗脱支架和西罗莫司洗脱支架用于阻塞性冠状动脉疾病患者的临床试验的荟萃分析。
Br J Clin Pharmacol. 2005 Jan;59(1):94-101. doi: 10.1111/j.1365-2125.2005.02258.x.
6
Drug-eluting stents: from randomized trials to the real world.药物洗脱支架：从随机试验到现实世界
Minerva Cardioangiol. 2004 Oct;52(5):349-63.
7
Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.西罗莫司洗脱支架与紫杉醇洗脱支架治疗冠状动脉初发病变的随机对照试验：REALITY试验
JAMA. 2006 Feb 22;295(8):895-904. doi: 10.1001/jama.295.8.895.
8
Could Paclitaxel-eluting stents be superior to sirolimus-eluting stents for the treatment of saphenous vein graft lesions?紫杉醇洗脱支架在治疗隐静脉桥病变方面是否优于西罗莫司洗脱支架？
Am J Cardiol. 2010 Nov 1;106(9):1367-8. doi: 10.1016/j.amjcard.2010.08.008.
9
Drug eluting stents: an updated meta-analysis of randomised controlled trials.药物洗脱支架：随机对照试验的最新荟萃分析
Heart. 2006 May;92(5):641-9. doi: 10.1136/hrt.2005.061622. Epub 2005 Oct 10.
10
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.西罗莫司洗脱支架或紫杉醇洗脱支架与球囊血管成形术预防冠状动脉支架内再狭窄患者复发的随机对照试验。
JAMA. 2005 Jan 12;293(2):165-71. doi: 10.1001/jama.293.2.165.
引用本文的文献
1
A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention.一项全基因组关联研究鉴定出 12 号染色体上的一个区域可能是经皮冠状动脉介入治疗后再狭窄的易感性位点。
Hum Mol Genet. 2011 Dec 1;20(23):4748-57. doi: 10.1093/hmg/ddr389. Epub 2011 Aug 30.
2
Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study.英国背景下药物洗脱冠状动脉支架置入术的成本效益：成本效用研究。
Heart. 2006 Jan;92(1):68-74. doi: 10.1136/hrt.2004.053850. Epub 2005 Apr 14.
本文引用的文献
1
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.西罗莫司洗脱支架与标准支架用于冠状动脉血运重建的随机对照研究。
N Engl J Med. 2002 Jun 6;346(23):1773-80. doi: 10.1056/NEJMoa012843.
2
Inhibition of restenosis with beta-emitting radiotherapy: Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT).
Circulation. 2000 Aug 29;102(9):951-8. doi: 10.1161/01.cir.102.9.951.
3
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.冠状动脉支架置入术与血小板糖蛋白IIb/IIIa受体阻滞剂的互补临床益处。支架置入术中血小板IIb/IIIa抑制作用评估研究组。
N Engl J Med. 1999 Jul 29;341(5):319-27. doi: 10.1056/NEJM199907293410503.
4
Dealing with in-stent restenosis.处理支架内再狭窄。
Heart. 1998 Apr;79(4):319-23. doi: 10.1136/hrt.79.4.319.
5
Catheter-based radiotherapy to inhibit restenosis after coronary stenting.
N Engl J Med. 1997 Jun 12;336(24):1697-703. doi: 10.1056/NEJM199706123362402.
6
A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group.冠状动脉疾病患者中球囊扩张式支架植入术与球囊血管成形术的比较。贝内斯特恩研究小组。
N Engl J Med. 1994 Aug 25;331(8):489-95. doi: 10.1056/NEJM199408253310801.
Zotero 插件